Related Experiment Videos
Ligand-receptor interactions as studied by PET: implications for drug development
1Department of Psychiatry, and the Turku PET Centre, Turku University Central Hospital, Finland. jarmo.hietala@utu.fi
Annals of Medicine
|February 19, 2000
Summary
Positron emission tomography (PET) offers molecular-level insights into human disease and drug action. This imaging technique is crucial for understanding drug-receptor interactions and optimizing drug development, particularly in neuroscience.
Area of Science:
- Nuclear medicine
- Molecular imaging
- Pharmacology
Background:
- Positron emission tomography (PET) is a quantitative imaging technique.
- Understanding in vivo ligand-receptor interactions remains a challenge.
- PET provides molecular-level insights into human pathophysiology.
Purpose of the Study:
- To highlight the utility of PET in characterizing molecular targets in vivo.
- To explore the application of PET in drug discovery and development.
- To emphasize PET's role in pharmacodynamic studies, particularly receptor occupancy.
Main Methods:
- Utilizing PET for quantitative imaging of molecular targets.
- Applying PET in both animal and human studies.
- Employing PET for receptor occupancy studies to verify drug mechanisms of action.
Main Results:
- PET enables characterization of binding properties of target molecules (receptors, transporters, enzymes).
- PET imaging generates unique molecular-level data in human studies.
- Receptor occupancy studies with PET are becoming standard for drug development.
Conclusions:
- PET is a powerful tool for in vivo molecular characterization and understanding complex biological systems.
- PET significantly aids in drug discovery, particularly in determining drug mechanisms and optimal dosing.
- The application of PET is expanding beyond the central nervous system to other therapeutic areas like cardiovascular diseases and oncology.